Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.35 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | CASP6 | P55212 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27905994 | 0.80 | NPC1 (0.36) | KAT2BBRD9MEN1USP2KMT2A | |
| SCHEMBL28113870 | 0.80 | KAT2B (0.33) | KAT2BBRD9MEN1USP2KMT2A | |
| SCHEMBL643988 | 0.73 | PARP1 (0.39) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL221825 | 0.71 | SLC9A1 (0.41) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL4656895 | 0.70 | DAO (0.37) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL16652006 | 0.70 | ADORA2A (0.36) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL9685966 | 0.70 | ALDH1A1 (0.37) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL11480635 | 0.70 | ADORA2A (0.36) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL25979874 | 0.70 | ADORA2A (0.36) | ADORA2AADORA2BMAPTALDH1A1LMNA | |
| SCHEMBL2078821 | 0.70 | ADORA2A (0.36) | ADORA2AADORA2BMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024231230-A2 | CIRCULAR NUCLEIC ACIDS AND USES THEREOF FOR SHAPING THE CELLULAR PROTEOME | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN KÖRPERSCHAFT DES ÖFFENTLICHEN RECHTS (DE) | 2024-11-14 | — | — | WO | disclosed |
| EP-4458968-A1 | CIRCULAR NUCLEIC ACIDS AND USES THEREOF FOR SHAPING THE CELLULAR PROTEOME | Justus-Liebig-Universität Gießen (DE) | 2024-11-06 | — | — | EP | disclosed |
| WO-2023130021-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED DELIVERY PROPERTIES | PHIO PHARMACEUTICALS CORP. (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023015264-A1 | IMMUNOTHERAPY OF CANCER UTILIZING NATURAL KILLER CELLS TREATED WITH CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-4055167-A2 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY | Phio Pharmaceuticals Corp. (US) | 2022-09-14 | — | — | EP | disclosed |
| EP-4008785-A1 | CIRCULAR NUCLEIC ACIDS AND USES THEREOF FOR INTERFERING WITH GENOME EXPRESSION AND PROLIFERATION OF CORONAVIRUSES | Justus-Liebig-Universität Gießen (DE) | 2022-06-08 | — | — | EP | disclosed |
| EP-3209335-A1 | AGENTS FOR USE IN THE DETECTION OF NUCLEASE ACTIVITY | Hernández Hincapié, Frank J. (ES) | 2017-08-30 | — | — | EP | disclosed |
| EP-3105330-A1 | MiR-21-3p INHIBITORS IN SKIN DISORDERS | Université de Lausanne (CH) | 2016-12-21 | — | — | EP | disclosed |
| CN-105658242-A | MRNA therapy for phenylketonuria | 夏尔人类遗传性治疗公司 | 2016-06-08 | — | — | CN | disclosed |
| WO-2015121395-A1 | MiR-21-3p INHIBITORS IN SKIN DISORDERS | UNIVERSITE DE LAUSANNE (CH) | 2015-08-20 | — | — | WO | disclosed |
| EP-2057273-A2 | USE OF SUBTILISIN (RNR9) POLYNUCLEOTIDES FOR ACHIEVING A PATHOGEN RESISTANCE IN PLANTS | BASF Plant Science GmbH (DE) | 2009-05-13 | — | — | EP | disclosed |
| EP-1979484-A1 | USE OF STOMATIN (STM1) POLYNUCLEOTIDES FOR ACHIEVING A PATHOGEN RESISTANCE IN PLANTS | BASF Plant Science GmbH (DE) | 2008-10-15 | — | — | EP | disclosed |
| EP-1948806-A2 | USE OF ARMADILLO REPEAT (ARM1) POLYNUCLEOTIDES FOR OBTAINING PATHOGEN RESISTANCE IN PLANTS | BASF Plant Science GmbH (DE) | 2008-07-30 | — | — | EP | disclosed |
| WO-2008087141-A2 | USE OF SUBTILISIN (RNR9) POLYNUCLEOTIDES FOR ACHIEVING A PATHOGEN RESISTANCE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2008-07-24 | — | — | WO | disclosed |
| US-20080120740-A1 | Novel Nucleic Acid Sequences and Their Use in Methods for Achieving a Pathogenic Resistance in Plants | BASF PLANT SCIENCE GMBH (DE) | 2008-05-22 | — | — | US | disclosed |
| WO-2007080143-A1 | USE OF STOMATIN (STM1) POLYNUCLEOTIDES FOR ACHIEVING A PATHOGEN RESISTANCE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2007-07-19 | — | — | WO | disclosed |
| WO-2007054441-A2 | USE OF ARMADILLO REPEAT (ARM1) POLYNUCLEOTIDES FOR OBTAINING PATHOGEN RESISTANCE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2007-05-18 | — | — | WO | disclosed |
| EP-1747275-A2 | NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING A PATHOGENIC RESISTANCE IN PLANTS | BASF Plant Science GmbH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005111215-A2 | NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING A PATHOGENIC RESISTANCE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| US-20030082678-A1 | Methods and compositions for regulating body weight in bovine species | ELI LILLY AND COMPANY | 2003-05-01 | — | — | US | disclosed |